• Users Online: 240
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 9  |  Issue : 2  |  Page : 70-76

Clinical evaluation of oily calcium hydroxide suspension alone and in combination with β-tricalcium phosphate in the treatment of periodontal intrabony defects


1 Department of Dentistry, GMERS Medical College and Hospital, Valsad, Gujarat, India
2 Department of Periodontics, Bangalore Institute of Dental Sciences, Bengaluru, Karnataka, India
3 Department of Periodontics, Government Dental College and Research Institute, Bengaluru, Karnataka, India

Correspondence Address:
Dr. Ankur G Shah
Department of Dentistry, GMERS Medical College and Hospital, Halar Road, Nanakwada, Valsad - 396 001 Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmd.ijmd_27_19

Rights and Permissions

Background: An oily calcium hydroxide suspension (OCHS) has been proved to be efficient in promoting bone regeneration in periodontal intrabony defects. However, the outcome of regenerative therapy using an OCHS as an adjunct to open-flap debridement is believed to be compromised by its low consistency. Thus, the present study was carried out to evaluate an OCHS alone and in combination with β-tricalcium phosphate (β-TCP) as a bone graft material in the treatment of periodontal intrabony defects. Materials and Methods: Twenty-six intrabony defects in 10 patients were divided into experimental and control sites. The experimental sites were debrided and grafted with a combination of OCHS and β-TCP. The control sites were debrided and grafted with OCHS alone. Probing pocket depth (PPD), clinical attachment level (CAL), and gingival margin position were recorded at baseline and at 3, 6, and 9 months. Results: No differences in any of the investigated parameters were observed at the baseline between the two groups. At 9 months postoperatively, the experimental group showed a reduction in mean PPD from 7.56 ± 1.15 to 4.19 ± 1.42 mm (P < 0.001) and a change in mean CAL from 8.00 ± 1.67 to 5.06 ± 2.17 mm (P < 0.001). In the control group, the mean PPD reduced from 7.90 ± 1.10 to 5.90 ± 1.52 mm (P < 0.05) and the mean CAL changed from 8.30 ± 1.16 to 6.40 ± 1.35 mm (P < 0.05). The experimental group demonstrated significantly higher PPD reduction and CAL gain than control group. Changes in the gingival margin position were nonsignificant in both the groups. Conclusion: Overall, both therapies led to significant PPD reduction and CAL gain. The combination of an OCHS and β-TCP as a bone graft material was more effective in terms of improving clinical parameters than OCHS alone.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1370    
    Printed166    
    Emailed0    
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal